Tariquidar (Standard)
Based on 1 Customer Validation
Tariquidar (Standard) is the analytical standard of Tariquidar. This product is intended for research and analytical applications. Tariquidar (XR9576) is a potent and specific inhibitor of P-glycoprotein (P-gp) with the high affinity (Kd=5.1 nM).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.18%
- CAS No.: 206873-63-4
- Formule: C38H38N4O6
- Masse moléculaire:646.73
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-10550
TariquidarP-gp Inhibitor -
HY-50671
Zosuquidar trihydrochlorideP-gp Inhibitor -
HY-15255
ZosuquidarP-gp Inhibitor -
HY-10550A
Tariquidar methanesulfonate, hydrateP-gp Inhibitor -
HY-50879
ElacridarP-gp And BCRP Dual-Inhibitor -
HY-17384
ValspodarP-glycoprotein Inhibitor -
HY-17013
DofequidarP-glycoprotein Inhibitor -
HY-13646
EncequidarP-glycoprotein Inhibitor -
HY-17013A
Dofequidar fumarateP-glycoprotein Inhibitor -
HY-13646A
Encequidar mesylateP-gp Inhibitor -
HY-50880
Elacridar hydrochlorideP-gp And BCRP Dual-Inhibitor -
HY-50879R
Elacridar (Standard)P-gp And BCRP Dual-Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 206873-63-4
-
Appearance Solid
-
Masse moléculaire 646.73
-
Formule C38H38N4O6
-
Color White to light yellow
-
SMILES
O=C(C1=CC2=CC=CC=C2N=C1)NC3=CC(OC)=C(OC)C=C3C(NC4=CC=C(CCN5CC6=C(C=C(OC)C(OC)=C6)CC5)C=C4)=O
-
Synonyms
XR9576 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Martin C, et al. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br J Pharmacol, 1999, 128(2), 403-411. [Content Brief]
[2]. Mistry P, et al. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res, 2001, 61(2), 749-758. [Content Brief]
[3]. Zimmermann ES, et al. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration. Antimicrob Agents Chemother. 2015 Nov 30;60(2):946-54. [Content Brief]
[4]. Kao YH, et al. Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone. J Cereb Blood Flow Metab. 2016 Aug;36(8):1412-23. [Content Brief]
[5]. Matzneller P, et al. Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. Eur J Drug Metab Pharmacokinet. 2018 Apr 3. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Tariquidar (Standard) Related Classifications
HY-10550R Related Classifications
Powered by Bioz